2022 Q4 Form 20-F Financial Statement
#000117891323000949 Filed on March 13, 2023
Income Statement
Concept | 2022 Q4 | 2022 | 2021 Q4 |
---|---|---|---|
Revenue | $72.63M | $239.8M | $63.42M |
YoY Change | 14.51% | 11.57% | 48.78% |
Cost Of Revenue | $44.91M | $152.9M | $38.83M |
YoY Change | 15.65% | 6.42% | 32.4% |
Gross Profit | $27.72M | $86.91M | $24.59M |
YoY Change | 12.71% | 21.95% | 84.89% |
Gross Profit Margin | 38.16% | 36.24% | 38.77% |
Selling, General & Admin | $11.50M | $40.54M | $10.23M |
YoY Change | 12.37% | 9.29% | 22.81% |
% of Gross Profit | 41.47% | 46.65% | 41.6% |
Research & Development | $10.10M | $35.64M | $8.452M |
YoY Change | 19.47% | 11623.68% | |
% of Gross Profit | 36.43% | 41.01% | 34.37% |
Depreciation & Amortization | $3.004M | $11.61M | $3.789M |
YoY Change | -20.72% | 5.61% | 49.76% |
% of Gross Profit | 10.84% | 13.36% | 15.41% |
Operating Expenses | $21.59M | $76.96M | $18.68M |
YoY Change | 15.58% | 12.45% | 21.79% |
Operating Profit | $6.123M | $9.953M | $5.908M |
YoY Change | 3.64% | 251.45% | -389.61% |
Interest Expense | -$102.0K | $3.816M | -$264.0K |
YoY Change | -61.36% | -1773.68% | 38.95% |
% of Operating Profit | -1.67% | 38.34% | -4.47% |
Other Income/Expense, Net | -$1.779M | ||
YoY Change | 19.08% | ||
Pretax Income | $5.968M | $7.135M | $4.993M |
YoY Change | 19.53% | 1454.47% | -92.02% |
Income Tax | $11.99M | $13.06M | $2.969M |
% Of Pretax Income | 200.87% | 183.08% | 59.46% |
Net Earnings | -$6.020M | -$5.928M | $2.024M |
YoY Change | -397.43% | 95.45% | -96.76% |
Net Earnings / Revenue | -8.29% | -2.47% | 3.19% |
Basic Earnings Per Share | -$0.10 | ||
Diluted Earnings Per Share | -$0.11 | -$0.10 | $35.80K |
COMMON SHARES | |||
Basic Shares Outstanding | 56.61M shares | 56.59M shares | |
Diluted Shares Outstanding | 56.59M shares |
Balance Sheet
Concept | 2022 Q4 | 2022 | 2021 Q4 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $86.59M | $86.59M | $81.86M |
YoY Change | 5.78% | 5.78% | -7.82% |
Cash & Equivalents | $86.59M | $86.59M | $81.86M |
Short-Term Investments | |||
Other Short-Term Assets | $19.28M | $19.82M | $23.95M |
YoY Change | -19.47% | 9.68% | -45.33% |
Inventory | $33.02M | $33.02M | $28.43M |
Prepaid Expenses | $6.404M | $5.857M | |
Receivables | $50.64M | $75.62M | $65.17M |
Other Receivables | $0.00 | $0.00 | $0.00 |
Total Short-Term Assets | $215.1M | $215.1M | $199.4M |
YoY Change | 7.85% | 7.85% | -14.57% |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | $76.58M | $80.47M | $76.87M |
YoY Change | -0.38% | 4.68% | -6.37% |
Goodwill | $43.47M | $43.47M | |
YoY Change | 0.0% | ||
Intangibles | $309.0K | $640.0K | |
YoY Change | -51.72% | ||
Long-Term Investments | |||
YoY Change | |||
Other Assets | $10.74M | $34.96M | $24.36M |
YoY Change | -55.92% | 43.53% | -6.32% |
Total Long-Term Assets | $170.4M | $170.4M | $168.3M |
YoY Change | 1.2% | 1.2% | 4.94% |
TOTAL ASSETS | |||
Total Short-Term Assets | $215.1M | $215.1M | $199.4M |
Total Long-Term Assets | $170.4M | $170.4M | $168.3M |
Total Assets | $385.4M | $385.4M | $367.7M |
YoY Change | 4.81% | 4.81% | -6.62% |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $20.67M | $20.67M | $19.78M |
YoY Change | 4.51% | 4.51% | -3.53% |
Accrued Expenses | $50.36M | $52.30M | $51.02M |
YoY Change | -1.3% | -16.47% | 5.63% |
Deferred Revenue | |||
YoY Change | |||
Short-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Long-Term Debt Due | $0.00 | ||
YoY Change | -100.0% | ||
Total Short-Term Liabilities | $125.8M | $125.8M | $108.5M |
YoY Change | 15.92% | 15.92% | -26.39% |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Other Long-Term Liabilities | $5.988M | $15.50M | $10.90M |
YoY Change | -45.08% | 42.14% | -13.46% |
Total Long-Term Liabilities | $15.50M | $15.50M | $10.90M |
YoY Change | 42.14% | 42.14% | -13.46% |
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $125.8M | $125.8M | $108.5M |
Total Long-Term Liabilities | $15.50M | $15.50M | $10.90M |
Total Liabilities | $141.3M | $141.3M | $119.4M |
YoY Change | 18.32% | 18.32% | -25.37% |
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$683.8M | -$677.9M | |
YoY Change | 0.87% | ||
Common Stock | $934.8M | $932.6M | |
YoY Change | 0.24% | ||
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | $244.1M | $244.1M | $248.3M |
YoY Change | |||
Total Liabilities & Shareholders Equity | $385.4M | $385.4M | $367.7M |
YoY Change | 4.81% | 4.81% | -6.62% |
Cashflow Statement
Concept | 2022 Q4 | 2022 | 2021 Q4 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | -$6.020M | -$5.928M | $2.024M |
YoY Change | -397.43% | 95.45% | -96.76% |
Depreciation, Depletion And Amortization | $3.004M | $11.61M | $3.789M |
YoY Change | -20.72% | 5.61% | 49.76% |
Cash From Operating Activities | $16.78M | $10.81M | $5.172M |
YoY Change | 224.52% | -42.79% | -91.44% |
INVESTING ACTIVITIES | |||
Capital Expenditures | $3.568M | $12.79M | -$3.909M |
YoY Change | -191.28% | -243.21% | 97.42% |
Acquisitions | $0.00 | ||
YoY Change | |||
Other Investing Activities | $4.006M | $4.629M | -$2.159M |
YoY Change | -285.55% | -314.4% | |
Cash From Investing Activities | $438.0K | -$8.164M | -$6.068M |
YoY Change | -107.22% | -26.4% | 206.46% |
FINANCING ACTIVITIES | |||
Cash Dividend Paid | $0.00 | ||
YoY Change | -100.0% | ||
Common Stock Issuance & Retirement, Net | $0.00 | ||
YoY Change | |||
Debt Paid & Issued, Net | $0.00 | ||
YoY Change | -100.0% | ||
Cash From Financing Activities | 0.000 | $0.00 | 0.000 |
YoY Change | -100.0% | -100.0% | |
NET CHANGE | |||
Cash From Operating Activities | 16.78M | $10.81M | 5.172M |
Cash From Investing Activities | 438.0K | -$8.164M | -6.068M |
Cash From Financing Activities | 0.000 | $0.00 | 0.000 |
Net Change In Cash | 17.22M | $2.682M | -896.0K |
YoY Change | -2022.1% | -108.6% | -102.33% |
FREE CASH FLOW | |||
Cash From Operating Activities | $16.78M | $10.81M | $5.172M |
Capital Expenditures | $3.568M | $12.79M | -$3.909M |
Free Cash Flow | $13.22M | -$1.979M | $9.081M |
YoY Change | 45.53% | -107.11% | -85.45% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2022 | dei |
Document Registration Statement
DocumentRegistrationStatement
|
false | |
CY2022 | dei |
Document Annual Report
DocumentAnnualReport
|
true | |
CY2022 | dei |
Document Transition Report
DocumentTransitionReport
|
false | |
CY2022 | dei |
Document Shell Company Report
DocumentShellCompanyReport
|
false | |
CY2022Q4 | us-gaap |
Short Term Investments
ShortTermInvestments
|
0 | usd |
CY2021Q4 | us-gaap |
Short Term Investments
ShortTermInvestments
|
2159000 | usd |
CY2022Q4 | us-gaap |
Assets Held For Sale Not Part Of Disposal Group Current
AssetsHeldForSaleNotPartOfDisposalGroupCurrent
|
0 | usd |
CY2021Q4 | us-gaap |
Assets Held For Sale Not Part Of Disposal Group Current
AssetsHeldForSaleNotPartOfDisposalGroupCurrent
|
4587000 | usd |
CY2022Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
usd | |
CY2021Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
usd | |
CY2022 | us-gaap |
Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
|
0 | usd |
CY2021 | us-gaap |
Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
|
0 | usd |
CY2020 | us-gaap |
Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
|
-53633000 | usd |
CY2022 | us-gaap |
Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
|
771000 | usd |
CY2021 | us-gaap |
Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
|
651000 | usd |
CY2020 | us-gaap |
Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
|
0 | usd |
CY2020 | us-gaap |
Dividends
Dividends
|
19999000 | usd |
CY2020 | us-gaap |
Dividends Cash
DividendsCash
|
35003000 | usd |
CY2020 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
-7463000 | usd |
CY2022 | us-gaap |
Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
|
4006000 | usd |
CY2021 | us-gaap |
Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
|
0 | usd |
CY2020 | us-gaap |
Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
|
0 | usd |
CY2022 | gilt |
Classification From Property And Equipment To Inventories
ClassificationFromPropertyAndEquipmentToInventories
|
0 | usd |
CY2021 | gilt |
Classification From Property And Equipment To Inventories
ClassificationFromPropertyAndEquipmentToInventories
|
0 | usd |
CY2020 | gilt |
Classification From Property And Equipment To Inventories
ClassificationFromPropertyAndEquipmentToInventories
|
155000 | usd |
CY2022 | gilt |
Dividends Declared From Noncash Transactions
DividendsDeclaredFromNoncashTransactions
|
0 | usd |
CY2021 | gilt |
Dividends Declared From Noncash Transactions
DividendsDeclaredFromNoncashTransactions
|
0 | usd |
CY2020 | gilt |
Dividends Declared From Noncash Transactions
DividendsDeclaredFromNoncashTransactions
|
35003000 | usd |
CY2022 | us-gaap |
Revenues
Revenues
|
239840000 | usd |
CY2021 | us-gaap |
Revenues
Revenues
|
214970000 | usd |
CY2020 | us-gaap |
Revenues
Revenues
|
166135000 | usd |
CY2021Q4 | gilt |
Retention Payable Credit
RetentionPayableCredit
|
2966000 | usd |
CY2021 | gilt |
Reduction In Cost Of Revenue
ReductionInCostOfRevenue
|
1679000 | usd |
CY2021 | gilt |
Reduction In Operation Expenses
ReductionInOperationExpenses
|
1287000 | usd |
CY2021Q4 | gilt |
Amount Receivable From Cares Act
AmountReceivableFromCaresAct
|
952000 | usd |
CY2022Q4 | gilt |
Amount Receivable From Cares Act
AmountReceivableFromCaresAct
|
952000 | usd |
CY2020 | us-gaap |
Advertising Expense
AdvertisingExpense
|
128000 | usd |
CY2021 | us-gaap |
Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
|
58000 | usd |
CY2022 | us-gaap |
Revenue Recognition Milestone Method Revenue Recognized
RevenueRecognitionMilestoneMethodRevenueRecognized
|
16169000 | usd |
CY2021 | us-gaap |
Revenue Recognition Milestone Method Revenue Recognized
RevenueRecognitionMilestoneMethodRevenueRecognized
|
22958000 | usd |
CY2020 | us-gaap |
Revenue Recognition Milestone Method Revenue Recognized
RevenueRecognitionMilestoneMethodRevenueRecognized
|
19470000 | usd |
CY2022 | us-gaap |
Amortization Of Deferred Sales Commissions
AmortizationOfDeferredSalesCommissions
|
3078000 | usd |
CY2021 | us-gaap |
Amortization Of Deferred Sales Commissions
AmortizationOfDeferredSalesCommissions
|
3028000 | usd |
CY2020 | us-gaap |
Amortization Of Deferred Sales Commissions
AmortizationOfDeferredSalesCommissions
|
1705000 | usd |
CY2022 | us-gaap |
Advertising Expense
AdvertisingExpense
|
309000 | usd |
CY2021 | us-gaap |
Advertising Expense
AdvertisingExpense
|
233000 | usd |
CY2022 | us-gaap |
Product Warranty Expense
ProductWarrantyExpense
|
233000 | usd |
CY2021 | us-gaap |
Product Warranty Expense
ProductWarrantyExpense
|
470000 | usd |
CY2020 | us-gaap |
Product Warranty Expense
ProductWarrantyExpense
|
49000 | usd |
CY2022 | gilt |
Research And Development Non Royalty Bearing Grants
ResearchAndDevelopmentNonRoyaltyBearingGrants
|
641000 | usd |
CY2021 | gilt |
Research And Development Non Royalty Bearing Grants
ResearchAndDevelopmentNonRoyaltyBearingGrants
|
1695000 | usd |
CY2020 | gilt |
Research And Development Non Royalty Bearing Grants
ResearchAndDevelopmentNonRoyaltyBearingGrants
|
1386000 | usd |
CY2022 | us-gaap |
Other Comprehensive Income Other Net Of Tax
OtherComprehensiveIncomeOtherNetOfTax
|
-490000 | usd |
CY2022 | us-gaap |
Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
|
-771000 | usd |
CY2021 | us-gaap |
Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
|
-651000 | usd |
CY2022Q4 | us-gaap |
Goodwill Gross
GoodwillGross
|
105647000 | usd |
CY2021Q4 | us-gaap |
Goodwill Gross
GoodwillGross
|
105647000 | usd |
CY2022Q4 | us-gaap |
Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
|
62179000 | usd |
CY2021Q4 | us-gaap |
Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
|
62179000 | usd |
CY2022Q4 | us-gaap |
Goodwill
Goodwill
|
43468000 | usd |
CY2021Q4 | us-gaap |
Goodwill
Goodwill
|
43468000 | usd |
CY2019Q4 | us-gaap |
Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
|
24864000 | usd |
CY2022Q4 | us-gaap |
Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
|
P2Y3M3D | |
CY2021Q4 | us-gaap |
Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
|
P2Y6M18D | |
CY2022Q4 | us-gaap |
Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
|
0.048 | pure |
CY2021Q4 | us-gaap |
Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
|
0.045 | pure |
CY2022Q4 | us-gaap |
Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
|
1934000 | usd |
CY2021Q4 | us-gaap |
Derivative Instruments In Hedges Assets At Fair Value
DerivativeInstrumentsInHedgesAssetsAtFairValue
|
24000 | usd |
CY2022Q4 | gilt |
Estimated Net Amount
EstimatedNetAmount
|
635000 | usd |
CY2019Q4 | us-gaap |
Dividends Payable Amount Per Share
DividendsPayableAmountPerShare
|
0.45 | |
CY2020Q4 | us-gaap |
Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
|
19999000 | usd |
CY2020Q4 | us-gaap |
Dividends Payable Amount Per Share
DividendsPayableAmountPerShare
|
0.36 | |
CY2021Q1 | us-gaap |
Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
|
35003000 | usd |
CY2021Q1 | us-gaap |
Dividends Payable Amount Per Share
DividendsPayableAmountPerShare
|
0.63 | |
CY2022 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
3.08 | |
CY2020 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
2.72 | |
CY2022 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
|
565000 | usd |
CY2021 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
|
14318000 | usd |
CY2020 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
|
424000 | usd |
CY2021Q4 | us-gaap |
Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
|
19999000 | usd |
CY2021Q4 | us-gaap |
Dividends Payable Amount Per Share
DividendsPayableAmountPerShare
|
0.36 | |
CY2021Q1 | us-gaap |
Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
|
35003000 | usd |
CY2021Q1 | us-gaap |
Dividends Payable Amount Per Share
DividendsPayableAmountPerShare
|
0.63 | |
CY2022Q4 | us-gaap |
Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
|
18265000 | usd |
CY2021Q4 | us-gaap |
Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
|
17551000 | usd |
CY2022 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
|
0.06 | pure |
CY2022Q4 | us-gaap |
Tax Credit Carryforward Valuation Allowance
TaxCreditCarryforwardValuationAllowance
|
115472000 | usd |
CY2021Q4 | us-gaap |
Tax Credit Carryforward Valuation Allowance
TaxCreditCarryforwardValuationAllowance
|
130663000 | usd |
CY2022 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
13063000 | usd |
CY2021 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
3492000 | usd |
CY2022 | gilt |
Capital Gain Loss From Merger Acquisition And Related Litigation Expense Net
CapitalGainLossFromMergerAcquisitionAndRelatedLitigationExpenseNet
|
0 | usd |
CY2021 | gilt |
Capital Gain Loss From Merger Acquisition And Related Litigation Expense Net
CapitalGainLossFromMergerAcquisitionAndRelatedLitigationExpenseNet
|
0 | usd |
CY2020 | gilt |
Capital Gain Loss From Merger Acquisition And Related Litigation Expense Net
CapitalGainLossFromMergerAcquisitionAndRelatedLitigationExpenseNet
|
7749000 | usd |
CY2022 | us-gaap |
Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
|
14940000 | usd |
CY2021 | us-gaap |
Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
|
1140000 | usd |
CY2020 | us-gaap |
Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
|
808000 | usd |
CY2022 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
1877000 | usd |
CY2021 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
2352000 | usd |
CY2020 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
-15000 | usd |
CY2020 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
793000 | usd |
CY2022 | us-gaap |
Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
|
12154000 | usd |
CY2021 | us-gaap |
Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
|
2719000 | usd |
CY2020 | us-gaap |
Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
|
325000 | usd |
CY2022 | us-gaap |
Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
|
909000 | usd |
CY2021 | us-gaap |
Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
|
773000 | usd |
CY2020 | us-gaap |
Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
|
468000 | usd |
CY2022 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
13063000 | usd |
CY2021 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
3492000 | usd |
CY2020 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
793000 | usd |
CY2022 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
|
-7523000 | usd |
CY2021 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
|
-5537000 | usd |
CY2020 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
|
44387000 | usd |
CY2022 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
|
14658000 | usd |
CY2021 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
|
5996000 | usd |
CY2020 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
|
-8518000 | usd |
CY2022 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
7135000 | usd |
CY2021 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
459000 | usd |
CY2020 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
35869000 | usd |
CY2022 | us-gaap |
Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
|
129000 | usd |
CY2022 | us-gaap |
Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
|
195000 | usd |
CY2022Q4 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
2908000 | usd |
CY2022Q4 | us-gaap |
Value Added Tax Receivable Current
ValueAddedTaxReceivableCurrent
|
3604000 | usd |
CY2021Q4 | us-gaap |
Value Added Tax Receivable Current
ValueAddedTaxReceivableCurrent
|
3727000 | usd |
CY2022Q4 | us-gaap |
Deferred Rent Credit Current
DeferredRentCreditCurrent
|
21000 | usd |
CY2021Q4 | us-gaap |
Deferred Rent Credit Current
DeferredRentCreditCurrent
|
617000 | usd |
CY2022Q4 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
5988000 | usd |
CY2022 | gilt |
Bank Charges
BankCharges
|
1752000 | usd |
CY2021 | gilt |
Bank Charges
BankCharges
|
1986000 | usd |
CY2020 | gilt |
Bank Charges
BankCharges
|
2201000 | usd |
CY2022 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-5928000 | usd |
CY2021 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-3033000 | usd |
CY2020 | us-gaap |
Net Income Loss
NetIncomeLoss
|
35076000 | usd |
CY2022 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
152932000 | usd |
CY2022 | us-gaap |
Gross Profit
GrossProfit
|
86908000 | usd |
CY2022 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
35640000 | usd |
CY2022 | us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
21694000 | usd |
CY2022 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
18850000 | usd |
CY2022 | us-gaap |
Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
|
771000 | usd |
CY2021 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
143703000 | usd |
CY2021 | us-gaap |
Gross Profit
GrossProfit
|
71267000 | usd |
CY2021 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
31336000 | usd |
CY2021 | us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
21512000 | usd |
CY2021 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
15587000 | usd |
CY2021 | us-gaap |
Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
|
651000 | usd |
CY2020 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
124755000 | usd |
CY2020 | us-gaap |
Gross Profit
GrossProfit
|
41380000 | usd |
CY2020 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
26303000 | usd |
CY2020 | us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
16871000 | usd |
CY2020 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
14063000 | usd |
CY2020 | us-gaap |
Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
|
-53633000 | usd |
CY2015 | us-gaap |
Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
|
1750000 | usd |